Nisa Investment Advisors LLC Sells 3,048 Shares of Humana Inc. (NYSE:HUM)

Nisa Investment Advisors LLC lessened its position in Humana Inc. (NYSE:HUM) by 9.4% during the 4th quarter, HoldingsChannel.com reports. The fund owned 29,413 shares of the insurance provider’s stock after selling 3,048 shares during the period. Nisa Investment Advisors LLC’s holdings in Humana were worth $7,488,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Creative Financial Designs Inc. ADV grew its stake in shares of Humana by 244.0% in the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 61 shares during the last quarter. Atwood & Palmer Inc. bought a new stake in Humana in the 3rd quarter valued at $29,000. Ashton Thomas Securities LLC bought a new stake in Humana in the 3rd quarter valued at $31,000. Your Advocates Ltd. LLP grew its position in Humana by 81.8% in the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock worth $32,000 after purchasing an additional 45 shares during the last quarter. Finally, LRI Investments LLC raised its position in shares of Humana by 1,021.4% during the third quarter. LRI Investments LLC now owns 157 shares of the insurance provider’s stock valued at $50,000 after buying an additional 143 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Stock Up 0.2 %

NYSE:HUM opened at $294.47 on Friday. The company has a market cap of $35.46 billion, a price-to-earnings ratio of 26.08, a P/E/G ratio of 2.15 and a beta of 0.55. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The stock’s fifty day moving average price is $274.02 and its two-hundred day moving average price is $305.79. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $406.46.

Humana (NYSE:HUM) last released its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. The company had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. On average, analysts anticipate that Humana Inc. will post 16.11 EPS for the current year.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the company. Cantor Fitzgerald reissued a “neutral” rating and set a $395.00 target price on shares of Humana in a research report on Tuesday, October 1st. Barclays lifted their price objective on Humana from $253.00 to $255.00 and gave the stock an “equal weight” rating in a report on Wednesday. Stephens restated an “equal weight” rating and issued a $250.00 target price on shares of Humana in a research note on Wednesday, October 9th. Leerink Partners downgraded shares of Humana from an “outperform” rating to a “market perform” rating and decreased their price target for the stock from $400.00 to $250.00 in a research note on Wednesday, October 2nd. Finally, Bank of America upgraded shares of Humana from an “underperform” rating to a “neutral” rating and increased their price objective for the company from $247.00 to $308.00 in a research note on Wednesday, November 6th. Twenty research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $302.80.

Insider Activity

In related news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 0.32% of the company’s stock.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.